<DOC>
	<DOCNO>NCT02843958</DOCNO>
	<brief_summary>This clinical trial new technology , name HEMOPTIC . It enable mesure time blood coagulation monitoring patient Vitamin K antagonist ( VKA ) . This device create alternative blood sample , do medical laboratory . The main goal evaluate accuracy International Normalized Ratio ( INR ) measurement new portable device diagnostic vitro , among healthy patient patient anti-vitamin K treatment .</brief_summary>
	<brief_title>Validation Portable Medical Device Diagnostic Vitro</brief_title>
	<detailed_description />
	<mesh_term>Vitamin K</mesh_term>
	<criteria>Inclusion Criteria healthy volunteer : Man woman 18 70 year Body Mass Index &gt; 18 &lt; 29 Absence acute pathology month precede study To affiliate beneficiary social security Exclusion Criteria healthy volunteer : Pregnant , partutient breastfeed woman Patient Raynaud 's syndrome Person deprive liberty legal administrative decision , person legal protection order Deferral period clinical study Annual threshold compensation attain biomedical search participation Inclusion Criteria patient : Man woman 18 80 year Patient treat oral anti vitamin K anticoagulant ( coumadine , warfarine , fluidione ) Absence acute pathology month precede study To affiliate beneficiary social security Exclusion Criteria healthy patient : Pregnant , partutient breastfeed woman Patient Raynaud 's syndrome Person deprive liberty legal administrative decision , person legal protection order Deferral period clinical study Annual threshold compensation attain biomedical search participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Medical device</keyword>
	<keyword>Hemoptic</keyword>
	<keyword>Vitamin K antagonist</keyword>
	<keyword>Diagnostic vitro</keyword>
</DOC>